Salinomycin, a potent inhibitor of XOD and URAT1, ameliorates hyperuricemic nephropathy by activating NRF2, modulating the gut microbiota, and promoting SCFA production
Article in Chemico-Biological Interactions (August 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Chemico-Biological Interactions (August 2024)
Article in Chinese Medical Journal (July 2024)
Article in Applied Microbiology (May 2024)